NCT06152809 2026-03-18CIML NK Cells With Venetoclax for AMLDana-Farber Cancer InstitutePhase 1 Recruiting10 enrolled
NCT06138587 2026-01-02Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell TransplantationDana-Farber Cancer InstitutePhase 1 Recruiting15 enrolled
NCT00534469 2025-12-02Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep RCity of Hope Medical CenterPhase 2 Completed60 enrolled 9 charts